HB-adMSC

BIOLOGICAL3 trials

Sponsors

Hope Biosciences Research Foundation

Conditions

COVID-19Chronic PainKnee Pain ChronicOsteo Arthritis Knee

Phase 2

Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19

TerminatedNCT04362189

Hope Biosciences Research FoundationCOVID-19

Start: 2020-06-30End: 2021-09-30Updated: 2025-09-26

Unknown Phase

Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.

Hope Biosciences Research FoundationKnee Pain Chronic, Osteo Arthritis Knee

Updated: 2025-09-29

Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.

Hope Biosciences Research FoundationChronic Pain

Updated: 2025-09-29

Related Papers

Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial

Frontiers in Medicine2023-12-225 citations